Every material Form 8-K Becton Dickinson filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Becton, Dickinson and Company elected two new independent directors, Robert L. Huffines and Jacqueline Wright, effective December 1, 2025, expanding the Board from twelve to fourteen members. The filing is an administrative board change with no reported effect on financial results, and it states the directors will receive prorated restricted stock unit grants.
Robert L. Huffines and Jacqueline Wright elected to the Board on November 17, 2025, effective December 1, 2025
Board size expands from twelve to fourteen members
Wright joins the Audit and Compensation and Human Capital Committees; Huffines joins the Audit and Corporate Governance and Nominating Committees
Both directors receive prorated restricted stock unit grants through the 2026 Annual Meeting of Shareholders; grant details to be disclosed by amendment
BD reported fiscal fourth-quarter 2025 revenue of $5.9 billion, up 8.3% as reported, and full-year fiscal 2025 revenue of $21.8 billion, up 8.2%. The company also gave fiscal 2026 guidance of adjusted diluted EPS of $14.75 to $15.05 and low single-digit revenue growth on a currency-neutral basis.
Q4 GAAP diluted EPS was $1.72, up 24.6% from $1.38; adjusted diluted EPS was $3.96, up 3.9%
FY25 GAAP diluted EPS was $5.82, down 0.7%; adjusted diluted EPS was $14.40, up 9.6%
FY26 guidance: adjusted diluted EPS of $14.75 to $15.05; GAAP revenue growth described as low single-digit plus
BD returned $2.2 billion to shareholders in FY25 through dividends and share repurchases
BD said its chief financial officer, Chris DelOrefice, will depart effective Dec. 5, 2025, to pursue a new professional opportunity, and Vitor Roque will serve as interim CFO while the company searches for a permanent successor. BD also reported preliminary unaudited fourth-quarter revenue of approximately $5.9 billion and full-year fiscal 2025 revenue of approximately $21.8 billion, both up on a reported basis, and said full-year adjusted diluted EPS is expected to be at or above the midpoint of its previous guidance.
Fourth-quarter preliminary revenue of approximately $5.9 billion, up approximately 8.3% reported and 3.9% organic
Full-year fiscal 2025 preliminary revenue of approximately $21.8 billion, up approximately 8.2% reported and 2.9% organic
Full-year adjusted diluted EPS expected at or above the midpoint of previously issued guidance
DelOrefice departs effective Dec. 5, 2025; Vitor Roque named interim CFO; earnings webcast set for Nov. 6, 2025
Becton, Dickinson and Company entered a third amended and restated senior unsecured revolving credit agreement with Citibank as administrative agent, replacing its prior January 2023 facility. The facility provides $2.75 billion of financing and can be increased by up to $500 million, to a maximum of $3.25 billion, subject to lender commitments. The filing sets out a leverage ratio covenant and says the company guarantees obligations of other borrowers.
Facility provides $2.75 billion; accordion option allows up to $3.25 billion aggregate commitment
Expires in September 2030, with possible extensions of up to two one-year periods
Covenant requires a Leverage Ratio of no more than 4.25:1.00, or 4.75:1.00 for five quarters after a material acquisition
Agreement dated September 16, 2025; BD Euro Finance S.à r.l. is authorized as a borrower
BD reported third-quarter fiscal 2025 revenue of $5.5 billion, up 10.4% as reported and 3.0% on an organic basis, with GAAP diluted EPS of $2.00 versus $1.68 a year earlier. The company raised its full-year adjusted diluted EPS guidance to $14.30 to $14.45 from $14.06 to $14.34 and reaffirmed its organic revenue growth outlook of 3.0% to 3.5%.
Q3 fiscal 2025 revenue of $5.5 billion, up 10.4% as reported; GAAP diluted EPS $2.00 vs. $1.68; adjusted diluted EPS $3.68 vs. $3.50
GAAP net income of $574 million vs. $487 million in the prior-year quarter
Full-year adjusted diluted EPS guidance raised to $14.30 to $14.45; organic revenue growth guidance reaffirmed at 3.0% to 3.5%
Nine-month GAAP net income fell 9.2% to $1.185 billion; a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters Corporation was announced in July
Becton, Dickinson and Company agreed on July 13, 2025 to combine its Biosciences and Diagnostic Solutions business with Waters Corporation through a spin-off and merger. BD expects to receive about $4 billion in cash, and its shareholders would own 39.2% of Waters after the deal, which both boards have unanimously approved.
BD receives approximately $4 billion in cash from SpinCo before the spin-off, subject to adjustments for cash, working capital and indebtedness.
BD shareholders would own 39.2% of the outstanding Waters common stock after the merger; existing Waters holders would own 60.8%.
Waters must pay BD a $733 million termination fee if the merger agreement is terminated under certain circumstances.
The merger must close by July 13, 2026, subject to extension tied to pending regulatory approvals, and requires Waters shareholder approval and antitrust clearance.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Becton Dickinson filing is on SEC EDGAR ↗. 8-K briefs of other companies →